SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-002121
Filing Date
2014-05-13
Accepted
2014-05-13 17:28:16
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20140331.htm 10-Q 2551651
2 EXHIBIT 31.1 abio-ex31_201403316.htm EX-31 9534
3 EXHIBIT 31.2 abio-ex31_201403317.htm EX-31 9497
4 EXHIBIT 32.1 abio-ex32_201403318.htm EX-32 12901
  Complete submission text file 0001564590-14-002121.txt   7586814

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20140331.xml EX-101.INS 794189
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20140331.xsd EX-101.SCH 46240
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20140331_cal.xml EX-101.CAL 41927
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20140331_def.xml EX-101.DEF 249787
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20140331_lab.xml EX-101.LAB 356468
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20140331_pre.xml EX-101.PRE 291931
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 14838521
SIC: 2835 In Vitro & In Vivo Diagnostic Substances